Søk i kliniske studier for: 50 microg. antigen adjuvant (500 nmol KLK 20 nmol ODN1a)
Totalt 3 resultater
-
Statens Serum InstitutFullført
-
Statens Serum InstitutFullført
-
University of Colorado, BoulderForest LaboratoriesFullført
Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.
Sponsorer og samarbeidspartnere
- St. Louis Children's Hospital
- PharmTest s.r.o.
- CK-CARE (Christine Kühne - Center for Allergy Research and Education)
- Tianjin Medical University
- Uzès hospital
- MRC/UVRI & LSHTM Uganda Research Unit
- Centre de Pharmacologie Clinique, INSERM CIC 501
- Marta Camats Terre
- Ministry of Tourism, Sport and the Arts, British Columbia
- Diabetech
- ViiV Healthcare Australia Pty. Ltd
- Medtronic Poland Spółka z ograniczoną odpowiedzialnością
- First Hospital Affiliated to Baotou Medical College, Baotou, China
- Medical School University of Zagreb
- Pyrotech Therapeutics, Inc.
- Etablissement Publique de Santé Mentale de la Réunion
- Jadran Galenski laboratorij d.d.Rijeka
- Incept BioSystems, Inc.
- Institutos Nacionales de Salud, USA Instituto Alemán del Cáncer
- Vaxxinity, Inc.
- Vis full liste
Medisinsk tilstand
- Ikke-nartritisk hoftesykdom
- Vasomotoriske symptomer assosiert med overgangsalder
- Post-Cerebrovaskulær Accident (CVA) Hemiparese
- Behandling av brystkreft
- Pulpotomi av unge permanente molarer
- Oralt allergisk syndrom
- Familiefunksjon
- Non-sedentary
- Hepatitt C, behandlingsnaive, genotype 1-pasienter
- Central Centrifugal Cicatricial Alopecia (CCCA)
- Native og ventil i aortaklaffsvikt
- Repository Corticotropin Injection
- Beinsykdom med høy turnover
- Fenofibrat
- Neoplasmer, avansert solid
- Kritisk sykdom Sepsis, alvorlig
- Human Papilloma Virus Infeksjon
- Kaste opp
- Godt trente idrettsutøvere
- Tilbakefallende ondartet solid svulst
- Vis full liste
Legemiddelintervensjoner
- Keytruda
- Eksperimentell DW224aa
- 0,45 % saltvann i 5 % dekstrose (intravenøst)
- Prazosin
- RoActemra sc
- Olorofim
- Karboplatin
- Fenelzinsulfat
- SPLA2 Inhibitor
- Svake steroider (Flurolon, Allergan)
- Sulfasalazine
- ASP2151
- Oksaliplatin
- SHR-1210
- Lidokain
- Famciclovir
- 40 consecutive doses of SUF NT 15 mcg taken every 20 minutes
- Ropivakain 0,2 %
- Durvalumab
- Tamsulosin
- Vis full liste
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in China
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Finland
- Contract Research Organizations in Greece
- Contract Research Organizations in Kenya
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Poland
- Contract Research Organizations in Romania
- Contract Research Organizations in Taiwan
- CRO list by country